| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/15/2002 | WO2002063293A1 Production of a monoclonal antibody by a transgenic avian |
| 08/15/2002 | WO2002063012A2 Ragweed allergens |
| 08/15/2002 | WO2002063010A2 Method of producing recombinant antibodies against tumors |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063007A2 TIMM8b-RELATED PROTEIN |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063005A2 Lipid-associated molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062998A1 Novel protein and dna thereof |
| 08/15/2002 | WO2002062990A1 Antibody and utilization thereof |
| 08/15/2002 | WO2002062972A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062852A1 Receptor protein expressed on cells |
| 08/15/2002 | WO2002062851A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | WO2002062850A2 Hybrid antibodies and uses thereof |
| 08/15/2002 | WO2002062847A2 Superficial zone protein and methods of making and using same |
| 08/15/2002 | WO2002062843A2 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | WO2002062842A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | WO2002062841A2 Secreted proteins |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062833A2 Modified leptin with reduced immunogenicity |
| 08/15/2002 | WO2002062832A2 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | WO2002062395A2 A method and system for introducing a gene into a human stem cell |
| 08/15/2002 | WO2002062383A2 Antagonists of myelin-associated glycoprotein and their use in the treatment and/or prevention of neurological diseases |
| 08/15/2002 | WO2002062375A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | WO2002062302A2 Steroidal derivatives |
| 08/15/2002 | WO2002062205A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062204A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002051871A3 Anti-cd28 antibody |
| 08/15/2002 | WO2002032937A3 Neuromedin u delta |
| 08/15/2002 | WO2002026249A3 Methods for inhibition of viral infection |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2002018554A3 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 08/15/2002 | WO2002014870A3 Use of antibodies against specific mhc-peptide complexes |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2002011757A3 Compositions and methods for inhibiting transmission of malaria |
| 08/15/2002 | WO2002008261A3 Bstp-trans protein and related reagents and methods of use thereof |
| 08/15/2002 | WO2001092321A3 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 08/15/2002 | WO2001066753A3 Human genes and gene expression products |
| 08/15/2002 | WO2001040309A9 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 08/15/2002 | WO2001032927A3 Tissue specific genes of diagnostic import |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020111473 Novel g protein coupled receptor |
| 08/15/2002 | US20020111472 T1-r ligand iii |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111469 Polypeptide for use in the treatment of tumors, lung defects, inflammation and heart defects |
| 08/15/2002 | US20020111463 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/15/2002 | US20020111462 Nuclelotide sequences coding peptide for use in the treatment of autoimmune diseases |
| 08/15/2002 | US20020111461 Peptidomimetic compound for us ein the treatment of diabetes |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111299 Family of peptides known as xenoxins |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110892 Human RNase H and compositions and uses thereof |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110888 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110871 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 08/15/2002 | US20020110870 Therapeutic applications for CCR5 chemokine receptors |
| 08/15/2002 | US20020110862 Novel Siglec-like gene |
| 08/15/2002 | US20020110859 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110805 Peptide for use in the treatment of glomerulonephritis, psoriasis, leukemia, antherosclerosis, autoimmune diseases, inflammatory, arthritic, asthmatic, and fibrotic disorders |
| 08/15/2002 | US20020110569 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/15/2002 | US20020110562 Streptococcus pneumoniae proteins and vaccines |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110558 For therapy |
| 08/15/2002 | US20020110556 Introducing labeled antibodies or labeled alpha-fetaprotein (AFP) to biological sample so they will react with AFP receptor or AFP receptor binding sites in biological sample; identifying AFP receptor or its binding sites in sample |
| 08/15/2002 | US20020110555 For therapy of microbial infection of a mammary gland in an animal |
| 08/15/2002 | CA2438221A1 Steroidal derivatives |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437573A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437570A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437484A1 Ragweed allergens |
| 08/15/2002 | CA2437453A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | CA2437265A1 Modified leptin with reduced immunogenicity |
| 08/15/2002 | CA2437263A1 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | CA2437185A1 Timm8b-related protein |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/14/2002 | EP1231271A2 DNA fragments of the GAG gene of Lav. |
| 08/14/2002 | EP1231270A1 Novel protein and dna thereof |
| 08/14/2002 | EP1231269A1 Methods and compositions for polypeptide engineering |
| 08/14/2002 | EP1231268A2 Polyclonal antibody libraries |
| 08/14/2002 | EP1231265A2 A receptor protein tyrosine kinase |
| 08/14/2002 | EP1231261A2 A method for isolating cells that express FLK-1 receptors on their surface |
| 08/14/2002 | EP1231260A2 A method for isolating cells that express FLK-2 receptors on their surface |
| 08/14/2002 | EP1230932A2 Use of antibodies for anticancer vaccination |
| 08/14/2002 | EP1230551A2 Methods to identify compounds that modulate neuronal activity |
| 08/14/2002 | EP1230396A2 Immunological detection of rna:dna hybrids on microarrays |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |
| 08/14/2002 | EP1230368A2 Mammalian receptor proteins; related reagents and methods |